These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 26607296

  • 1. Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators.
    Drastikova M, Beranek M, Gabalec F, Netuka D, Masopust V, Cesak T, Marek J, Palicka V, Cap J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):238-43. PubMed ID: 26607296
    [Abstract] [Full Text] [Related]

  • 2. Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.
    Gabalec F, Drastikova M, Cesak T, Netuka D, Masopust V, Machac J, Marek J, Cap J, Beranek M.
    Physiol Res; 2015 Jun; 64(3):369-77. PubMed ID: 25536318
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T, Kato M, Tani Y, Oyama K, Yamada S, Hirata Y.
    Endocr J; 2009 Jun; 56(4):579-84. PubMed ID: 19318729
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
    Horiguchi K, Yamada M, Umezawa R, Satoh T, Hashimoto K, Tosaka M, Yamada S, Mori M.
    Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.
    Taboada GF, Luque RM, Bastos W, Guimarães RF, Marcondes JB, Chimelli LM, Fontes R, Mata PJ, Filho PN, Carvalho DP, Kineman RD, Gadelha MR.
    Eur J Endocrinol; 2007 Jan; 156(1):65-74. PubMed ID: 17218727
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion.
    Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890
    [Abstract] [Full Text] [Related]

  • 7. Protein expression of somatostatin receptor 2, somatostatin receptor 5 and dopamine D2 receptor in normal pituitary gland and ACTH-secreting pituitary adenoma in dogs.
    Sato A, Hara Y.
    Res Vet Sci; 2018 Aug; 119():61-66. PubMed ID: 29864631
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Somatostatin and dopamine-somatostatin multiple ligands directed towards somatostatin and dopamine receptors in pituitary adenomas.
    Saveanu A, Gunz G, Guillen S, Dufour H, Culler MD, Jaquet P.
    Neuroendocrinology; 2006 Apr; 83(3-4):258-63. PubMed ID: 17047391
    [Abstract] [Full Text] [Related]

  • 11. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction.
    Murabe H, Shimatsu A, Ihara C, Mizuta H, Nakamura Y, Nagata I, Kikuchi H, Nakao K.
    J Neuroendocrinol; 1996 Aug; 8(8):605-10. PubMed ID: 8866248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T, Thellung S, Corsaro A, Bocca L, Arena S, Pattarozzi A, Villa V, Massa A, Diana F, Schettini D, Barbieri F, Ravetti JL, Spaziante R, Giusti M, Schettini G.
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
    Corbetta S, Ballaré E, Mantovani G, Lania A, Losa M, Di Blasio AM, Spada A.
    Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
    Jaquet P, Gunz G, Saveanu A, Barlier A, Dufour H, Taylor J, Dong J, Kim S, Moreau JP, Culler MD.
    J Endocrinol Invest; 2005 Mar; 28(11 Suppl International):21-7. PubMed ID: 16625841
    [Abstract] [Full Text] [Related]

  • 17. SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary.
    Lee M, Lupp A, Mendoza N, Martin N, Beschorner R, Honegger J, Schlegel J, Shively T, Pulz E, Schulz S, Roncaroli F, Pellegata NS.
    Endocr Relat Cancer; 2015 Feb; 22(1):111-9. PubMed ID: 25515731
    [Abstract] [Full Text] [Related]

  • 18. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
    van der Pas R, Feelders RA, Gatto F, de Bruin C, Pereira AM, van Koetsveld PM, Sprij-Mooij DM, Waaijers AM, Dogan F, Schulz S, Kros JM, Lamberts SW, Hofland LJ.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin receptor profile in pituitary thyrotroph adenomas.
    Thodou E, Kontogeorgos G.
    Clin Neurol Neurosurg; 2020 Aug; 195():105865. PubMed ID: 32416325
    [Abstract] [Full Text] [Related]

  • 20. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
    Saveanu A, Jaquet P, Brue T, Barlier A.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):206-13. PubMed ID: 18241980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.